COVID-19, the disease caused by SARS-CoV-2, has caused significant morbidity and mortality worldwide. The betacoronavirus continues to evolve with global health implications as we race to learn more to curb its transmission, evolution, and sequelae. The focus of this review, the second of a three-part series, is on the biological effects of the SARS-CoV-2 virus on post-acute disease in the context of tissue and organ adaptations and damage. We highlight the current knowledge and describe how virological, animal, and clinical studies have shed light on the mechanisms driving the varied clinical diagnoses and observations of COVID-19 patients. Moreover, we describe how investigations into SARS-CoV-2 effects have informed the understanding of viral pathogenesis and provide innovative pathways for future research on the mechanisms of viral diseases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10772081PMC
http://dx.doi.org/10.1038/s41431-023-01462-1DOI Listing

Publication Analysis

Top Keywords

effects sars-cov-2
8
comprehensive sars-cov-2
4
sars-cov-2 covid-19
4
covid-19 review
4
review host
4
host extracellular
4
extracellular systemic
4
systemic effects
4
sars-cov-2
4
sars-cov-2 infection
4

Similar Publications

Background: Virtual follow-up (VFU) has the potential to enhance cancer survivorship care. However, a greater understanding is needed of how VFU can be optimized.

Objective: This study aims to examine how, for whom, and in what contexts VFU works for cancer survivorship care.

View Article and Find Full Text PDF

SARS-CoV-2 has continued spreading around the world in recent years since the initial outbreak in 2019, frequently developing into new variants with greater human infectious capacity. SARS-CoV-2 and its mutants use the angiotensin-converting enzyme 2 (ACE2) as a cellular entry receptor, which has triggered several therapeutic strategies against COVID-19 relying on the use of ACE2 recombinant proteins as decoy receptors. In this work, we propose an ACE2 silent Fc fusion protein (ACE2-hFcLALA) as a candidate therapy against COVID-19.

View Article and Find Full Text PDF

Based on nationally representative panel data (N person-years = 40,020; N persons = 18,704; Panel Labour Market and Social Security; PASS) from 2018 to 2022, we investigate how mental health changed during and after the COVID-19 pandemic. We employ time-distributed fixed effects regressions to show that mental health (Mental Health Component Summary Score of the SF-12) decreased from the first COVID-19 wave in 2020 onward, leading to the most pronounced mental health decreases during the Delta wave, which began in August 2021. In the summer of 2022, mental health had not returned to baseline levels.

View Article and Find Full Text PDF

Aims: To describe the characteristics and quality of caring interactions between nurses and patients during the earlier phases of the COVID-19 pandemic in acute and home care settings.

Background: Nurse-patient interaction (NPI) plays an important role in effective, person-centered care delivery and has been impacted by the COVID-19 pandemic.

Methods: The survey was part of a multimethod study and used a cross-sectional design.

View Article and Find Full Text PDF

A new extended Chen distribution for modelling COVID-19 data.

PLoS One

January 2025

Department of Mathematics, College of Science, University of Hafr Al Batin, Hafar Al-Batin, Saudi Arabia.

In this paper, we propose a new flexible statistical distribution, the Topp-Leone Exponentiated Chen distribution, to model real-world data effectively, with a particular focus on COVID-19 data. The motivation behind this study is the need for a more flexible distribution that can capture various hazard rate shapes (e.g.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!